🇮🇳IN
Sign In
JE

JENBURPH

NSE

Jenburkt Pharmaceuticals Ltd

₹963.05

-5.10(-0.53%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

JENBURPH valuation summary

Jenburkt Pharmaceuticals Ltd trades at 11.4 times trailing earnings. Return on equity is 20.2% and return on capital employed is 27.0%. The dividend yield is 2.24%. That P/E equals an earnings yield of 8.8%. The median P/E across 101 listed Drug Manufacturers - Specialty & Generic companies is 35.0, so Jenburkt Pharmaceuticals Ltd trades at a 63% discount to that median.

P/E11.4
ROE20.2%
ROCE27.0%
Dividend yield2.24%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer